IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26
IOL Chemicals & Pharmaceuticals Ltd · Financial Result · 30 Oct 2026, 11:29 pm
IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 795 (+40.1% YoY | +5.1% QoQ) ■ EBITDA: 109 (+91.7% YoY | +5.7% QoQ) ■ EBITDA Margin (%): 13.8 (+371 bps YoY | +8 bps QoQ) ■ PAT: 65.1 (+117.1% YoY | +1.0% QoQ) ■ EPS (INR): 2.22 (+117.6% YoY | +1.4% QoQ) IOL Chemicals & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) Segmental Performance Pharmaceutical ■ Revenue: 473 (+40.5% YoY | +0.7% QoQ) ■ EBIT: 68.1 (+92.0% YoY | -1.1% QoQ) ■ EBIT Margin (%): 14.4 (+386 bps YoY | -26 bps QoQ) Chemical ■ Revenue: 394 (+38.3% YoY | +8.1% QoQ) ■ EBIT: 23.2 (+359.0% YoY | +33.8% QoQ) ■ EBIT Margin (%): 5.9 (+411 bps YoY | +113 bps QoQ)
Original exchange filing (PDF)
More announcements from IOL Chemicals & Pharmaceuticals Ltd
- Clarification on increase in Volume · 11 Nov 2026
- The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on November 11, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. · 11 Nov 2026
- Transcript of Earning Call on the Q2 & H1 FY27 Financial Results · 05 Nov 2026
- Audio Recording of Earnings Call on the Q2 & H1 FY 27 Financial Results · 02 Nov 2026
- Investor Presentation- Q2 & H1 FY27 · 02 Nov 2026
- Press Release · 31 Oct 2026
- Outcome of the Board Meeting and submission of Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026 · 30 Oct 2026
- IOL Chemicals and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
